Jack Bendheim, President and CEO of Phibro Animal Health Corporation, reported the sale of 14,080 shares of Common Stock via indirect open-market transactions on Feb. 13 and Feb. 18, 2026, for total proceeds of approximately $728,000, according to a SEC Form 4 filing.
https://www.fool.com/coverage/filings/2026/02/27/phibro-animal-health-s-ceo-sold-over-14-000-shares-is-the-stock-a-buy-or-sell/